# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-007283
Filing Date
2024-01-26
Accepted
2024-01-26 16:27:10
Documents
7
Period of Report
2024-03-06

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm242571-1_def14a.htm | DEF 14A | 1101625
2 | GRAPHIC | bc_netloss-4clr.jpg | GRAPHIC | 144721
3 | GRAPHIC | bc_tsr-4clr.jpg | GRAPHIC | 181933
4 | GRAPHIC | lg_essa-4c.jpg | GRAPHIC | 18651
5 | GRAPHIC | lg_laurelhilladvgrp-4c.jpg | GRAPHIC | 47476
6 | GRAPHIC | px_24essaproxy01page01-4c.jpg | GRAPHIC | 373723
7 | GRAPHIC | px_24essaproxy01page02-bw.jpg | GRAPHIC | 304806
| Complete submission text file | 0001104659-24-007283.txt |  | 2524931

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-37410 | Film No.: 24568288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)